Selected publications
-
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology.
2016
Review
GET IT
Times cited: 5 -
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Breast Cancer Research.
2015
Academic Article
GET IT
Times cited: 13 -
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Nature Genetics.
2015
Review
GET IT
Times cited: 129 -
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Nature Genetics.
2013
Academic Article
GET IT
Times cited: 341 -
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
PLoS Genetics.
2013
Academic Article
GET IT
Times cited: 167 -
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer Epidemiology Biomarkers and Prevention.
2012
Academic Article
GET IT
Times cited: 33 -
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Research.
2011
Academic Article
GET IT
Times cited: 48